Cancer-induced bone pain

Lesley A. Colvin, Marie T. Fallon

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Bone is the third most common site of metastatic disease, after liver and lung, with approximately 75% of these patients suffering from related pain. Cancer-induced bone pain (CIBP) is a major clinical problem, with limited options for predictable, rapid, and effective treatment for some of the elements without unacceptable adverse effects. Our understanding of how current therapy acts is based mainly on studies in non-cancer pain syndromes, which are likely to be quite different, not only in clinical presentation, but also in terms of pathophysiology. It can be difficult to study the specific neurobiological changes associated with CIBP, although development of laboratory models of isolated bone metastases has allowed more specific study of pain mechanisms in this syndrome. In order to evaluate our current therapies properly and direct the development of new therapies logically, it is important to understand the underlying mechanisms of CIBP. This chapter discusses pain processing and the mechanisms and management of CIBP.
Original languageEnglish
Title of host publicationOxford Textbook of Palliative Medicine
EditorsNathan Cherny, Marie Fallon, Stein Kaasa, Russell K. Portenoy, David C. Currow
Place of PublicationOxford
PublisherOxford University Press
Pages841-859
Number of pages19
Edition5
ISBN (Print)9780199656097
DOIs
Publication statusPublished - Mar 2015

Fingerprint Dive into the research topics of 'Cancer-induced bone pain'. Together they form a unique fingerprint.

Cite this